Drug Shortage Report for MULTI 12 INJECTION

Last updated on 2021-05-19 History
Report ID 129582
Drug Identification Number 02100606
Brand name MULTI 12 INJECTION
Common or Proper name MULTI 12 INJECTION
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ASCORBIC ACID VITAMIN A VITAMIN D VITAMIN B1 VITAMIN B2 NICOTINAMIDE PYRIDOXINE HYDROCHLORIDE DEXPANTHENOL VITAMIN E BIOTIN FOLIC ACID VITAMIN B12
Strength(s) 20MG 660UNIT 40UNIT 0.6MG 0.72MG 8MG 0.8MG 3MG 2UNIT 12MCG 80MCG 1MCG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 vials of 25ml
ATC code B05XC
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2020-12-03
Estimated end date 2022-03-05
Actual end date
Shortage status Actual shortage
Updated date 2021-05-19
Company comments Customers can order 44002609 / 6410 MULTI-12 5ML 10LIVI CA / UPC 057513064104 / DIN 02100606 as a substitute.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-05-19 French Compare
v8 2021-05-19 English Compare
v7 2021-01-19 French Compare
v6 2021-01-19 English Compare
v5 2020-12-09 French Compare
v4 2020-12-09 English Compare
v3 2020-12-03 French Compare
v2 2020-12-03 English Compare
v1 2020-12-03 English Compare

Showing 1 to 9 of 9